INS and Hypoglycemia: This recommendation was primarily based on a large single-center trial in surgical ICU patients showing a survival benefit with intensive insulin therapy (blood glucose maintained at 80–110 mg/dL) compared to conventional insulin therapy (blood glucose maintained at <215 mg/dL), despite a higher risk of hypoglycemia in the intensive insulin group [184].